Breadcrumb

CTB News

Eva Kaufmann receives award from the German Society for Immunology

Eva Kaufmann, DVM, PhD, a postdoctoral student in the lab of Maziar Divangahi, PhD, at the Research Institute of the McGill University Health...

Scientific breakthrough: promising new target for immunotherapy

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of...

High-dose flu vaccine improves immune response in rheumatoid arthritis

“People living with rheumatoid arthritis (RA) have an increased risk for influenza infection and influenza-related illness,” as Inès Colmegna...

No-Nonsense Approach to Genetic Kidney Disease in Children

The Research Institute of the McGill University Health Centre’s (RI-MUHC) push to treat a rare genetic disease in children...

New means to fight 'un-killable' bacteria in healthcare settings

Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant...

Preterm birth: The "Nodal" gene under the microscope

Preterm birth is a major global public health problem. Every year, 15 million babies are born prematurely and many will suffer from...

Dr. David Rosenblatt to receive Lifetime Achievement Award

Dr. David Rosenblatt, Holder, Dodd Q. Chu and Family Chair in Medical Genetics and Professor, Departments of Human Genetics, Medicine...

As harmful as dehydration?

We are all familiar with the drawbacks of dehydration, but we rarely hear about the harmful effects of overhydration. It is known...

Beyond Killing Tuberculosis

Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease. However, this perspective...

Extraordinary $15-million gift will create unique powerhouse initiative to fight infections

A $15-million gift from the visionary Montreal-based Doggone Foundation will launch the McGill Interdisciplinary Initiative in Infection and...

Explore news and events at the RI-MUHC